QYUNS-B Spends HKD 0.80 Million to Repurchase 51,400 H-Shares, Raising Treasury Stock to 3.55 Million

Bulletin Express

Jun 11

Qyuns Therapeutics Co., Ltd. (abbrev. QYUNS-B) disclosed a next-day return showing it bought back 51,400 H-shares on 11 June 2026 through on-market transactions, deploying HKD 0.80 million at prices between HKD 14.80 and HKD 15.80 per share. The repurchased amount equals 0.023 % of the company’s issued share base (excluding treasury shares) before the transaction.

Following the buyback, issued shares remain at 227.07 million, while treasury shares rose to 3.55 million. Outstanding shares available for trading now stand at 223.52 million.

The transaction was executed under the share-repurchase mandate approved on 29 May 2026, which authorises up to 22.44 million shares. Cumulative repurchases since the mandate total 839,000 shares, representing 0.37 % of the issued share count on the mandate date. A 30-day moratorium on new share issues or treasury-share disposals extends through 11 July 2026, in accordance with Hong Kong Main Board rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1196812736"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196812736\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1196812736?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 22:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196812736","market":"us","top_or_hot":-1,"title":"QYUNS-B Spends HKD 0.80 Million to Repurchase 51,400 H-Shares, Raising Treasury Stock to 3.55 Million","media":"Bulletin Express","content":"<p>Qyuns Therapeutics Co., Ltd. (abbrev. QYUNS-B) disclosed a next-day return showing it bought back 51,400 H-shares on 11 June 2026 through on-market transactions, deploying HKD 0.80 million at prices between HKD 14.80 and HKD 15.80 per share. The repurchased amount equals 0.023 % of the company’s issued share base (excluding treasury shares) before the transaction.</p>\n<p>Following the buyback, issued shares remain at 227.07 million, while treasury shares rose to 3.55 million. Outstanding shares available for trading now stand at 223.52 million.</p>\n<p>The transaction was executed under the share-repurchase mandate approved on 29 May 2026, which authorises up to 22.44 million shares. Cumulative repurchases since the mandate total 839,000 shares, representing 0.37 % of the issued share count on the mandate date. A 30-day moratorium on new share issues or treasury-share disposals extends through 11 July 2026, in accordance with Hong Kong Main Board rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QYUNS-B Spends HKD 0.80 Million to Repurchase 51,400 H-Shares, Raising Treasury Stock to 3.55 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQYUNS-B Spends HKD 0.80 Million to Repurchase 51,400 H-Shares, Raising Treasury Stock to 3.55 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-11 22:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics Co., Ltd. (abbrev. QYUNS-B) disclosed a next-day return showing it bought back 51,400 H-shares on 11 June 2026 through on-market transactions, deploying HKD 0.80 million at prices between HKD 14.80 and HKD 15.80 per share. The repurchased amount equals 0.023 % of the company’s issued share base (excluding treasury shares) before the transaction.</p>\n<p>Following the buyback, issued shares remain at 227.07 million, while treasury shares rose to 3.55 million. Outstanding shares available for trading now stand at 223.52 million.</p>\n<p>The transaction was executed under the share-repurchase mandate approved on 29 May 2026, which authorises up to 22.44 million shares. Cumulative repurchases since the mandate total 839,000 shares, representing 0.37 % of the issued share count on the mandate date. A 30-day moratorium on new share issues or treasury-share disposals extends through 11 July 2026, in accordance with Hong Kong Main Board rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1196812736","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196812736","pubTimestamp":1781186436,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics Co., Ltd. (abbrev. QYUNS-B) disclosed a next-day return showing it bought back 51,400 H-shares on 11 June 2026 through on-market transactions, deploying HKD 0.80 million at prices...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"QYUNS-B斥资80万港元回购5.14万股H股库存股增至355万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics Co., Ltd. (abbrev. QYUNS-B) disclosed a next-day return showing it bought back 51,400 H-shares on 11 June 2026 through on-market transactions, deploying HKD 0.80 million at prices between HKD 14.80 and HKD 15.80 per share. The repurchased amount equals 0.023 % of the company’s issued share base (excluding treasury shares) before the transaction.\nFollowing the buyback, issued shares remain at 227.07 million, while treasury shares rose to 3.55 million. Outstanding shares available for trading now stand at 223.52 million.\nThe transaction was executed under the share-repurchase mandate approved on 29 May 2026, which authorises up to 22.44 million shares. Cumulative repurchases since the mandate total 839,000 shares, representing 0.37 % of the issued share count on the mandate date. A 30-day moratorium on new share issues or treasury-share disposals extends through 11 July 2026, in accordance with Hong Kong Main Board rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}